Skip to main content
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc. — Investor Relations & Filings

Ticker · MRKR ISIN · US57055L1070 US Manufacturing
Open in API
Filings indexed 899 across all filing types
Latest filing 2012-11-15 Regulatory Filings
Country US United States of America
Listing US MRKR

About Marker Therapeutics, Inc.

https://markertherapeutics.com/

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company developing next-generation T cell-based immunotherapies for hematologic malignancies and solid tumors. The company's core technology is its Multi-Antigen Recognizing (MAR) T cell platform, which utilizes natural, non-genetically modified T cells to recognize and kill heterogeneous tumors. This approach is designed to provide durable anti-tumor responses with a favorable safety profile. Its lead product candidate, MT-601, recognizes six tumor-specific antigens and is being evaluated in a Phase 1 study for patients with lymphoma who have relapsed or are ineligible for anti-CD19 CAR-T cell therapy. The technology was originally developed at Baylor College of Medicine.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2012
Regulatory Filings Classification · 100% confidence The document is a Form 12B-25, which is a Notification of Late Filing for a Form 10-Q quarterly report. It states that the quarterly report for the period ended September 30, 2012, has not been completed due to administrative delays and will be filed soon. The document does not contain actual financial data or substantive financial analysis but is a regulatory notification about the delay in filing the quarterly report. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document and not the report itself.
2012-11-15 English
Capital/Financing Update 2012
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving the issuance of a note convertible into common stock, including terms of the note and conversion rights. There are no financial statements or comprehensive financial data presented, nor is this an annual or quarterly report. The document is not a full earnings release or management discussion but rather an update on financing activity. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it contains substantive information about a financing transaction, not just an announcement of a report publication or a certification. Hence, the classification is CAP with high confidence.
2012-10-24 English
TPIV 10QA
Interim / Quarterly Report Q2 2012
2012-09-12 English
RESIGNATION
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated August 23, 2012, reporting the resignation of a director, Lynn DePippo. The key content is the departure of a board member, which falls under announcements related to changes in the company's board of directors or senior management. The document does not contain financial statements or detailed financial data, nor is it an earnings release or annual report. It is specifically about management changes, so the appropriate classification is Board/Management Information (MANG). The document length is short and focused solely on this event, confirming the classification.
2012-08-30 English
Interim / Quarterly Report 2012
Interim / Quarterly Report Q2 2012
2012-08-20 English
Capital/Financing Update 2012
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement involving a debenture issuance and related financing terms. It includes details about the debt instrument, conversion rights, and related financial obligations. There are no financial statements or comprehensive financial data presented, only an announcement of a financing event. The document length is 4167 characters, which is relatively short and consistent with an 8-K filing. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory certification or voting announcement. Therefore, the correct classification is CAP with high confidence.
2012-08-20 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.